Expression Profiling of Serous Low Malignant Potential, Low-Grade, and High-Grade Tumors of the Ovary
Top Cited Papers
- 15 November 2005
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 65 (22) , 10602-10612
- https://doi.org/10.1158/0008-5472.can-05-2240
Abstract
Papillary serous low malignant potential (LMP) tumors are characterized by malignant features and metastatic potential yet display a benign clinical course. The role of LMP tumors in the development of invasive epithelial cancer of the ovary is not clearly defined. The aim of this study is to determine the relationships among LMP tumors and invasive ovarian cancers and identify genes contributing to their phenotypes. Affymetrix U133 Plus 2.0 microarrays (Santa Clara, CA) were used to interrogate 80 microdissected serous LMP tumors and invasive ovarian malignancies along with 10 ovarian surface epithelium (OSE) brushings. Gene expression profiles for each tumor class were used to complete unsupervised hierarchical clustering analyses and identify differentially expressed genes contributing to these associations. Unsupervised hierarchical clustering analysis revealed a distinct separation between clusters containing borderline and high-grade lesions. The majority of low-grade tumors clustered with LMP tumors. Comparing OSE with high-grade and LMP expression profiles revealed enhanced expression of genes linked to cell proliferation, chromosomal instability, and epigenetic silencing in high-grade cancers, whereas LMP tumors displayed activated p53 signaling. The expression profiles of LMP, low-grade, and high-grade papillary serous ovarian carcinomas suggest that LMP tumors are distinct from high-grade cancers; however, they are remarkably similar to low-grade cancers. Prominent expression of p53 pathway members may play an important role in the LMP tumor phenotype.Keywords
All Related Versions
This publication has 45 references indexed in Scilit:
- Whole genome expression profiling of advance stage papillary serous ovarian cancer reveals activated pathwaysOncogene, 2004
- Eukaryotic MCM Proteins: Beyond Replication InitiationMicrobiology and Molecular Biology Reviews, 2004
- Identification of cJun-responsive genes in Rat-1a cells using multiple techniques: increased expression of stathmin is necessary for cJun-mediated anchorage-independent growthOncogene, 2003
- Molecular determinants of tumor differentiation in papillary serous ovarian carcinomaMolecular Carcinogenesis, 2003
- The Transformation Suppressor Pdcd4 Is a Novel Eukaryotic Translation Initiation Factor 4A Binding Protein That Inhibits TranslationMolecular and Cellular Biology, 2003
- Altered adhesion properties and alpha v integrin expression in a cisplatin‐resistant human ovarian carcinoma cell lineInternational Journal of Cancer, 2001
- PML interaction with p53 and its role in apoptosis and replicative senescenceOncogene, 2001
- Bcl-2 and p53 Protein Expression, Apoptosis, and p53 Mutation in Human Epithelial Ovarian CancersThe American Journal of Pathology, 2000
- Absence of Radiation-induced G1 Arrest in Two Closely Related Human Lymphoblast Cell Lines That Differ in p53 StatusPublished by Elsevier ,1995
- The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNANature, 1994